Posted on: 14 November, 2025
Northern Sydney Local Health District hosted the latest stop on Sydney Health Partners’ 2025 roadshow, Translation in Action.
More than 70 researchers and clinicians gathered at the Kolling Institute to hear presentations by colleagues involved in translational research projects, and to see how Sydney Health Partners is assisting research translation.
The Kolling’s Academic Director Professor James.....
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, New Treatment, Research Excellence
Posted on: 03 November, 2025
Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics capabilities, with AGRF – the Australian Genome Research Facility - establishing a laboratory within the institute.
The new lab is part of an exciting partnership between AGRF, the University of Sydney and the Kolling which will see a specialised team and cutting-edge technology located within the ins.....
Read more
Category: Research Excellence, World-leading technology
Posted on: 31 October, 2025
A heavy Christmas lunch, an argument or even smoke from a bushfire may seem harmless, but for people at risk of heart disease, they could be deadly.
A new study is investigating how emotional stress, pollution, chest infections, and large meals can trigger heart attacks in vulnerable people, and importantly, how to manage those triggers in the moment.
Royal North Shore Hospital cardiologist and Kol.....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 24 October, 2025
As we live longer and there are more people living into old age, there is an increasing number of people developing dementia with more than 400,000 people currently living with the condition in Australia.
Dementia is now the leading cause of death in Australia, and Alzheimer’s disease is the most common cause of dementia.
Dementia Australia warns that in the absence of a significant medical breakth.....
Read more
Category: Neuroscience and Pain Research, New Treatment
Posted on: 17 October, 2025
Leading pain specialist Professor Chris Vaughan is stepping down after a career spanning close to three decades.
As a Principal Hospital Scientist, Chris has successfully juggled roles as a researcher, mentor and educator at Royal North Shore Hospital, the Kolling Institute and the University of Sydney.
He has had a profound impact on the field of pain research, advancing our understanding of pain,.....
Read more
Category: Research Excellence
Posted on: 13 October, 2025
The latest global health check has confirmed heart disease remains the world’s biggest killer.
The concerning trend was identified through the Global Burden of Disease study which analysed health challenges and the leading cause of death in Australia and across the world. The study looked at data over more than three decades from 1990 to 2023.
Kolling Institute researcher and Royal North Shore Hosp.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 09 October, 2025
Co-inciding with World Arthritis Day (12 October), researchers from the University of Sydney and the Kolling Institue are urging the community to avoid low-value osteoarthritis care, in favour of evidenced-based resources to help manage the condition.
Osteoarthritis is the most common form of arthritis and one of the leading causes of disability globally. It affects over 2 million people in Austral.....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 23 September, 2025
Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert team of researchers, including some promising progress with our bowel cancer investigators.
There's an opportunity to join a clinical trial to minimise the impact of osteoarthritis, a new approach to reduce spinal cord injury related pain and an international award recognising 40 years of service .....
Read more
Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, New Treatment, Research Excellence
Posted on: 22 September, 2025
Bowel cancer is the third most common type of cancer in Australia and treating it is both costly and complex. Alarmingly, rates are rising among people under 50, and researchers still don’t know why.
It is for these reasons that Professor Mark Molloy is on a mission to prevent the disease in the first place. Based in the Kolling Institute, the leading bowel cancer research specialist is runnin.....
Read more
Category: Research Excellence
Posted on: 15 September, 2025
After more than 25 years leading visionary research, Professor Ian Cameron has stepped down as the head of the internationally respected John Walsh Centre for Rehabilitation Research.
Accomplished researcher, educator and clinician Professor Ashley Craig has been appointed to the role and will lead a large team of experienced and emerging investigators.
Dr Mohit Arora steps into the new position of.....
Read more
Category: Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence